Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Feasibility and First in Human Study of the YANG System for Continuous Monitoring of Glucose, Ketones and Lactate - The GLOW Study

NCT04782934 is registered in ClinicalTrials.gov with Indigo Diabetes NV as lead sponsor.

NCT NCT04782934
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04782934 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Feasibility and First in Human Study of the YANG System for Continuous Monitoring of Glucose, Ketones and Lactate - The GLOW Study
Lead sponsor
Indigo Diabetes NV
Phase
Not applicable
Overall status
Completed
Start date
February 25, 2021
Completion date
June 19, 2021
Enrollment
7 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus, glucose